欧洲旅行疫苗市场预测至 2028 年 – COVID-19 影响和分析 – 按产品（甲型肝炎、乙型肝炎、脑膜炎球菌疫苗等）和应用（国内旅行和出境旅行）
No. of Pages: 132 | Report Code: BMIRE00025498 | Category: Life Sciences
No. of Pages: 132 | Report Code: BMIRE00025498 | Category: Life Sciences
肝炎、艾滋病毒/艾滋病、人类该地区发现了乳头瘤病毒（HPV）、脑膜炎球菌病、伤寒和黄热病等多种慢性疾病。同样，2021年，美国疾病控制与预防中心（CDC）启动了2021-2030年全球免疫战略框架。该框架提供了针对甲型肝炎和乙型肝炎等疫苗可预防疾病（VPD）的疫苗接种计划。此外，世卫组织还为旅行者提出了不同的疫苗接种程序，以防止致命传染病的传播。疫苗常规包括旅行前审查的常规疫苗、针对某些目的地的疫苗以及某些国家要求的疫苗。在大多数情况下，如果人们没有遵守常规时间表，则需要注射加强剂量的常规疫苗。世卫组织和疾病预防控制中心的此类举措增加了疫苗需求，从而推动了其市场增长。另一方面，新冠肺炎 (COVID-19) 疫情的爆发威胁着公众健康。疫情期间，各国启动了各种紧急行动，其中“COVAX”倡议得到大力实施。全世界人民都必须接种新冠肺炎 (COVID-19) 疫苗。每个地区的政府都强制要求境内外旅行的人接种疫苗。 COVID-19 大流行对旅行疫苗做出了重大贡献。因此，上述因素正在推动市场增长。
借助新功能和技术，供应商可以吸引新客户并扩大业务范围涉足新兴市场。这一因素可能会推动欧洲旅行疫苗市场。预计欧洲旅行疫苗市场在预测期内将以良好的复合年增长率增长。
欧洲旅行疫苗市场细分
欧洲旅行疫苗市场分为产品、应用和国家。欧洲旅行疫苗市场按产品分为甲型肝炎、乙型肝炎、脑膜炎球菌疫苗等。 2021年，其他细分市场占据最大市场份额。欧洲旅行疫苗市场按用途分为国内旅行和出境旅行。 2021年，出境游细分市场占据最大份额。根据国家/地区，欧洲旅行疫苗市场分为法国、德国、意大利、英国、俄罗斯和欧洲其他地区。
雅培； Dynavax 技术；紧急生物解决方案公司；葛兰素史克公司；默克公司有限公司；诺华公司；辉瑞公司；赛诺菲；和 Valneva SE 是该地区旅行疫苗市场的领先公司之一。
Strategic insights for Europe Travel Vaccines involve closely monitoring industry trends, consumer behaviours, and competitor actions to identify opportunities for growth. By leveraging data analytics, businesses can anticipate market shifts and make informed decisions that align with evolving customer needs. Understanding these dynamics helps companies adjust their strategies proactively, enhance customer engagement, and strengthen their competitive edge. Building strong relationships with stakeholders and staying agile in response to changes ensures long-term success in any market.
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 995.47 Million |
| Market Size by 2028 | US$ 1,885.56 Million |
| Global CAGR (2021 - 2028) | 9.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By 产品
|
| Regions and Countries Covered | 欧洲
|
| Market leaders and key company profiles |
The regional scope of Europe Travel Vaccines refers to the geographical area in which a business operates and competes. Understanding regional nuances, such as local consumer preferences, economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved regions or adapting their offerings to meet regional demands. A clear regional focus allows for more effective resource allocation, targeted marketing, and better positioning against local competitors, ultimately driving growth in those specific areas.
The Europe Travel Vaccines Market is valued at US$ 995.47 Million in 2021, it is projected to reach US$ 1,885.56 Million by 2028.
As per our report Europe Travel Vaccines Market, the market size is valued at US$ 995.47 Million in 2021, projecting it to reach US$ 1,885.56 Million by 2028. This translates to a CAGR of approximately 9.6% during the forecast period.
The Europe Travel Vaccines Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Travel Vaccines Market report:
The Europe Travel Vaccines Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Europe Travel Vaccines Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Europe Travel Vaccines Market value chain can benefit from the information contained in a comprehensive market report.
Office No. 1011, First floor, Farena Corporate Park, Magarpatta-Mundhwa road, Pune - 411028, Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Europe Travel Vaccines Market
